SEC Comment Letter 0000000000-24-012796 to Climb Bio, Inc. (CLYM) (CIK 0001768446) (CLYM)
Climb Bio, Inc. (CLYM) (CIK 0001768446)
Date: Nov. 19, 2024 · CIK: 0001768446 · Accession: 0000000000-24-012796
AI Filing Summary & Sentiment
File numbers found in text: 333-283166
Letter
November 19, 2024 Aoife Brennan, M.B., Ch.B. President and Chief Executive Officer Climb Bio, Inc. 20 William Street, Suite 145 Wellesley Hills, Massachusetts 02481 Re:Climb Bio, Inc. Registration Statement on Form S-3 Filed November 12, 2024 File No. 333-283166 Dear Aoife Brennan M.B., Ch.B.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Scott N. Lunin
Show Raw Text
November 19, 2024
Aoife Brennan, M.B., Ch.B.
President and Chief Executive Officer
Climb Bio, Inc.
20 William Street, Suite 145
Wellesley Hills, Massachusetts 02481
Re:Climb Bio, Inc.
Registration Statement on Form S-3
Filed November 12, 2024
File No. 333-283166
Dear Aoife Brennan M.B., Ch.B.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Scott N. Lunin